🇺🇸 Intermittent bolus infusion of levobupivacaine in United States

Intermittent bolus infusion of levobupivacaine (Intermittent bolus infusion of levobupivacaine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intermittent bolus infusion of levobupivacaine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intermittent bolus infusion of levobupivacaine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intermittent bolus infusion of levobupivacaine in United States?

University Hospital, Antwerp is the originator. The local marketing authorisation holder may differ — check the official source linked above.